{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:16:20Z","timestamp":1770066980767,"version":"3.49.0"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> In dialysis patients, cardiac troponin T (cTNT) is often elevated despite the absence of acute myocardial ischaemia, and amino\u2010terminal pro\u2010B\u2010natriuretic peptide (NT\u2010proBNP) is markedly higher compared to non\u2010haemodialysis patients. In a longitudinal observation, we evaluated the association of cTNT and NT\u2010proBNP on cardiovascular morbidity and mortality in haemodialysis patients with and without fluid overload.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> Plasma cTNT levels of 134 haemodialysis patients were measured before and after a dialysis session by 3rd generation electro\u2010chemoluminiscence immunoassay. NT\u2010proBNP was determined using a polyclonal antibody recognizing the N\u2010terminal fragment of BNP (Elecsys autoanalyzer 2010, Roche Diagnostics, Mannheim, Germany). Volume status was determined by a clinical score system. Cardiovascular morbidity and mortality were assessed over a follow\u2010up period of 36\u00a0months.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Plasma cTNT &gt; 0\u00b703\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup> was found in 39\u00b76% of all patients. Patients with hypervolaemia had significantly higher cTNT levels compared to euvolaemic patients (median 0\u00b7054\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup>, interquartile range 0\u00b7019\u20130\u00b7153 vs. 0\u00b7005\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup>,\u00a0&lt;\u00a00\u00b7001\u20130\u00b7034; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001). All haemodialysis patients had excessively high levels of NT\u2010proBNP (median 4524; interquartile range 2000\u201310\u00a0250\u00a0pg\u00a0mL<jats:sup>\u22121<\/jats:sup>), and NT\u2010proBNP was significantly higher in hypervolaemic haemodialysis patients (11\u00a0988, 5307\u201319\u00a0242) compared to euvolaemic haemodialysis patients (3247, 1619\u20135574); <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001. Receiver operator curves showed a threshold of cTNT &gt; 0\u00b7026\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup> and NT\u2010proBNP &gt; 5300\u00a0pg\u00a0mL<jats:sup>\u22121<\/jats:sup> as predictors of hypervolaemia. Asymptomatic chronic haemodialysis patients with cTNT &gt; 0\u00b7026\u00a0ng\u00a0mL<jats:sup>\u22121<\/jats:sup> and NT\u2010proBNP &gt; 5300\u00a0pg\u00a0mL<jats:sup>\u22121<\/jats:sup> were more likely to die due to cardiac events in the follow\u2010up period. Multivariate analysis documented that elevated cTNT and NT\u2010proBNP levels were highly predictive for cardiovascular events.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Plasma levels of cTNT are elevated in approximately 40% and NT\u2010proBNP levels in 100% of asymptomatic chronic haemodialysis patients. Both parameters depend on volume status. Increased NT\u2010proBNP and cTNT are strongly associated with adverse outcome in end\u2010stage renal disease patients undergoing haemodialysis, and are a useful tool for risk stratification in chronic haemodialysis patients.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2007.01785.x","type":"journal-article","created":{"date-parts":[[2007,5,6]],"date-time":"2007-05-06T09:48:25Z","timestamp":1178444905000},"page":"350-356","source":"Crossref","is-referenced-by-count":84,"title":["Cardiac biomarkers and survival in haemodialysis patients"],"prefix":"10.1111","volume":"37","author":[{"given":"C.","family":"Sommerer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Beimler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Heckele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Giannitsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"521","article-title":"Comparison of cardiac troponin T and troponin I assays \u2013 implications of analytical and biochemical differences on clinical performance","volume":"50","author":"Giannitsis E","year":"2004","journal-title":"Clin Lab"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.3.353"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.8.1961"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.16.1964"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.035741"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.7.1452"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33914"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000109483.45211.8F"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.04.007"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/089686080602600314","article-title":"Association between serum n\u2010terminal pro\u2010brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients","volume":"26","author":"Lee JA","year":"2006","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.030692"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2006.01594.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00641.2005"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.06.017"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000081662.64171.9B"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/34.1.27"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/clinchem\/44.5.930","article-title":"Cardiac troponin T in patients with end\u2010stage renal disease: absence of expression in truncal skeletal muscle","volume":"44","author":"Haller C","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001605"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000135543.93270.D2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00641.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.11.090"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.025"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01276.2004"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.09.038"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.8.1948"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.V75667","article-title":"Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine","volume":"7","author":"T\u00f6rnig J","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2006.02.005"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.560128"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147611.92021.2B"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2007.01785.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2007.01785.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:29:13Z","timestamp":1697430553000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2007.01785.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,24]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1365-2362.2007.01785.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2007.01785.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,24]]}}}